Silverback Therapeutics Inc (SBTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SBTX | AZN | AMGN | GILD | BMY |
| Company | Silverback Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 5.82 | 200.57 | 375.47 | 147.01 | 61.85 |
| High | 6.15 | 200.57 | 375.47 | 147.01 | 61.85 |
| Low | 5.72 | 200.57 | 375.47 | 147.01 | 61.85 |
| Latest | 5.87 | 199.00 | 375.24 | 146.25 | 61.83 |
| Change | +0.06 | -2.53 | -4.03 | -1.97 | -0.50 |
| % Change | +1.03% | -1.26% | -1.06% | -1.33% | -0.80% |
| Volume | 116,700 | 11,045 | 5,154 | 9,363 | 9,701 |
| 20-Day Average Volume | 195,280 | 2,303,627 | 2,681,893 | 7,502,348 | 13,170,490 |
| Previous Close | 5.81 | 201.53 | 379.27 | 148.22 | 62.33 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.79 | 202.24 | 376.47 | 150.21 | 61.00 |
| 20-Day Raw Stochastic | 60.38% | 53.54% | 47.77% | 27.61% | 78.79% |
| 20-Day Relative Strength | 54.62 | 54.47 | 57.08 | 55.42 | 62.45 |
| Weighted Alpha | -17.00 | +37.06 | +25.57 | +34.59 | +16.23 |
| Today's Opinion | 100% Buy | 88% Buy | 88% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 100% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 56% Buy | 72% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.55% since 11/01/22 | -1.67% since 02/26/26 | -1.02% since 02/26/26 | +2.25% since 02/26/26 | +1.23% since 02/26/26 |
| Low | 5.72 on 11/08/22 | 197.10 on 03/03/26 | 370.82 on 03/04/26 | 143.37 on 02/27/26 | 60.43 on 03/03/26 |
| High | 6.46 on 11/02/22 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 62.89 on 03/02/26 |
| 1-Month | |||||
| %Chg | +11.81% since 10/07/22 | +7.16% since 02/05/26 | +2.09% since 02/05/26 | -1.58% since 02/05/26 | +3.91% since 02/05/26 |
| Low | 4.91 on 10/13/22 | 187.06 on 02/09/26 | 361.00 on 02/11/26 | 143.09 on 02/26/26 | 59.23 on 02/19/26 |
| High | 6.50 on 10/31/22 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | +17.87% since 08/08/22 | +11.21% since 12/05/25 | +13.82% since 12/05/25 | +21.28% since 12/05/25 | +18.60% since 12/05/25 |
| Low | 4.45 on 09/23/22 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 50.33 on 12/10/25 |
| High | 6.50 on 10/31/22 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +94.37% since 05/06/22 | +22.75% since 09/05/25 | +32.38% since 09/05/25 | +27.78% since 09/05/25 | +31.20% since 09/05/25 |
| Low | 2.80 on 05/12/22 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 6.50 on 10/31/22 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 211,660 | 312,554,496 | 204,452,320 | 184,003,424 | 126,933,432 |
| Shares Outstanding, K | 36,058 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -89,480,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -17,860,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.60 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.50 on 11/02/22 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/30/23 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.03 | 17.25 | 18.14 | 9.95 |